Cardinal Health Case Study: Using Real-World Evidence to Expedite Regulatory Approval

When seeking expedited regulatory approval, biopharmaceutical companies need authoritative real-world evidence (RWE) to make their case. In a new case study, Cardinal Health shows how their RWE and Insights team’s efforts helped seal the deal on FDA-accelerated approval for a biopharmaceutical company. In addition, their product had a strong market entrance.

According to Cardinal Health, “The Cardinal Health team leveraged their Oncology Provider Extended Network (OPEN), an expansive research network of community physicians to help identify the desired population. In just a few months, they were able to increase the study sample and secure a higher percentage of matches with the required covariances than the national registries and academic institutes the client had originally relied on. By directly engaging with individual healthcare providers, there was no need to set up costly site-based infrastructure.”

Click here to download the free case study.

(Source: Cardinal Health, February 16^th, 2022)